169,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

Addressing a topic of utmost importance in the field, this text addresses the epidemiology, diagnosis, assessment, and management of patients with metabolic syndrome-focusing on implications for cardiovascular disease risk. With an abundance of clearly organized tables, flowcharts, and practice guidelines, this blue-ribbon source succinctly analyzes recent clinical trials, compares and assesses recent and emerging therapies, and provides recommendations for the improved assessment and treatment of patients, while supplying a state-of-the-art overview of approaches to optimize and enhance patient care.…mehr

Produktbeschreibung
Addressing a topic of utmost importance in the field, this text addresses the epidemiology, diagnosis, assessment, and management of patients with metabolic syndrome-focusing on implications for cardiovascular disease risk. With an abundance of clearly organized tables, flowcharts, and practice guidelines, this blue-ribbon source succinctly analyzes recent clinical trials, compares and assesses recent and emerging therapies, and provides recommendations for the improved assessment and treatment of patients, while supplying a state-of-the-art overview of approaches to optimize and enhance patient care.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Andrew J. Krentz, Nathan D. Wong